Trials / Recruiting
RecruitingNCT07381803
The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction
The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction: A Randomized Clinical Trial (FEND Ⅱ)
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,804 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fexofenadine 60 Mg Oral Tablet | Fexofenadine, 60mg BID oral |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2025-01-27
- Primary completion
- 2026-12-01
- Completion
- 2027-06-01
- First posted
- 2026-02-02
- Last updated
- 2026-02-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07381803. Inclusion in this directory is not an endorsement.